vs
Side-by-side financial comparison of Insulet Corporation (PODD) and REPUBLIC AIRWAYS HOLDINGS INC. (RJET). Click either name above to swap in a different company.
REPUBLIC AIRWAYS HOLDINGS INC. is the larger business by last-quarter revenue ($1.1B vs $783.7M, roughly 1.4× Insulet Corporation). Over the past eight quarters, Insulet Corporation's revenue compounded faster (33.2% CAGR vs 3.9%).
An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin therapy . The device configuration may vary depending on design. A traditional pump includes:the pump a disposable reservoir for insulin a disposable infusion set, including a cannula for subcutaneous insertion and a tubing system to connect the insulin reservoir to the cannula.
Republic Airways Holdings Inc. is an American airline holding company based in Indianapolis, Indiana. The company owns two regional airlines, Mesa Airlines and Republic Airways. Together the two airlines operate the world's largest fleet of Embraer 170 and Embraer 175 aircraft. The majority of the shares of company are owned by the mainline carriers that contract with Republic, American Airlines Group, Delta Air Lines, and United Airlines.
PODD vs RJET — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $783.7M | $1.1B |
| Net Profit | $101.6M | — |
| Gross Margin | 72.6% | — |
| Operating Margin | 18.7% | 22.0% |
| Net Margin | 13.0% | — |
| Revenue YoY | 31.2% | — |
| Net Profit YoY | 0.9% | — |
| EPS (diluted) | $1.42 | $3.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $783.7M | $1.1B | ||
| Q3 25 | $706.3M | $90.7M | ||
| Q2 25 | $649.1M | $92.8M | ||
| Q1 25 | $569.0M | $94.7M | ||
| Q4 24 | $597.5M | $808.3M | ||
| Q3 24 | $543.9M | — | ||
| Q2 24 | $488.5M | $110.8M | ||
| Q1 24 | $441.7M | $131.6M |
| Q4 25 | $101.6M | — | ||
| Q3 25 | $87.6M | $-14.1M | ||
| Q2 25 | $22.5M | $20.9M | ||
| Q1 25 | $35.4M | $-58.6M | ||
| Q4 24 | $100.7M | $97.8M | ||
| Q3 24 | $77.5M | — | ||
| Q2 24 | $188.6M | $-19.9M | ||
| Q1 24 | $51.5M | $11.7M |
| Q4 25 | 72.6% | — | ||
| Q3 25 | 72.2% | — | ||
| Q2 25 | 69.7% | — | ||
| Q1 25 | 71.9% | — | ||
| Q4 24 | 72.1% | — | ||
| Q3 24 | 69.3% | — | ||
| Q2 24 | 67.7% | — | ||
| Q1 24 | 69.5% | — |
| Q4 25 | 18.7% | 22.0% | ||
| Q3 25 | 16.7% | -10.1% | ||
| Q2 25 | 18.7% | -0.2% | ||
| Q1 25 | 15.6% | -60.4% | ||
| Q4 24 | 18.3% | 18.7% | ||
| Q3 24 | 16.2% | — | ||
| Q2 24 | 11.2% | -8.1% | ||
| Q1 24 | 12.9% | 8.8% |
| Q4 25 | 13.0% | — | ||
| Q3 25 | 12.4% | -15.6% | ||
| Q2 25 | 3.5% | 22.5% | ||
| Q1 25 | 6.2% | -61.9% | ||
| Q4 24 | 16.9% | 12.1% | ||
| Q3 24 | 14.2% | — | ||
| Q2 24 | 38.6% | -18.0% | ||
| Q1 24 | 11.7% | 8.9% |
| Q4 25 | $1.42 | $3.13 | ||
| Q3 25 | $1.24 | $-0.34 | ||
| Q2 25 | $0.32 | $0.50 | ||
| Q1 25 | $0.50 | $-1.42 | ||
| Q4 24 | $1.38 | $2.42 | ||
| Q3 24 | $1.08 | — | ||
| Q2 24 | $2.59 | $-0.48 | ||
| Q1 24 | $0.73 | $0.28 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $296.5M |
| Total DebtLower is stronger | $930.8M | $882.9M |
| Stockholders' EquityBook value | $1.5B | $1.3B |
| Total Assets | $3.2B | $3.3B |
| Debt / EquityLower = less leverage | 0.61× | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $296.5M | ||
| Q3 25 | — | $38.7M | ||
| Q2 25 | — | $42.5M | ||
| Q1 25 | — | $54.1M | ||
| Q4 24 | — | $302.0M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $16.3M | ||
| Q1 24 | — | $18.5M |
| Q4 25 | $930.8M | $882.9M | ||
| Q3 25 | $934.9M | $27.0M | ||
| Q2 25 | $939.0M | $28.2M | ||
| Q1 25 | $1.6B | $31.7M | ||
| Q4 24 | $1.3B | $752.2M | ||
| Q3 24 | $1.4B | — | ||
| Q2 24 | $1.4B | $287.7M | ||
| Q1 24 | $1.4B | $299.0M |
| Q4 25 | $1.5B | $1.3B | ||
| Q3 25 | $1.4B | $-52.6M | ||
| Q2 25 | $1.5B | $-38.7M | ||
| Q1 25 | $1.3B | $-59.8M | ||
| Q4 24 | $1.2B | $1.1B | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $998.4M | $134.9M | ||
| Q1 24 | $790.7M | $154.7M |
| Q4 25 | $3.2B | $3.3B | ||
| Q3 25 | $3.0B | $158.9M | ||
| Q2 25 | $3.5B | $178.6M | ||
| Q1 25 | $3.5B | $215.0M | ||
| Q4 24 | $3.1B | $2.8B | ||
| Q3 24 | $3.0B | — | ||
| Q2 24 | $2.9B | $664.4M | ||
| Q1 24 | $2.6B | $706.3M |
| Q4 25 | 0.61× | 0.66× | ||
| Q3 25 | 0.68× | — | ||
| Q2 25 | 0.64× | — | ||
| Q1 25 | 1.21× | — | ||
| Q4 24 | 1.07× | 0.68× | ||
| Q3 24 | 1.21× | — | ||
| Q2 24 | 1.36× | 2.13× | ||
| Q1 24 | 1.72× | 1.93× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $183.3M | — |
| Free Cash FlowOCF − Capex | $48.2M | — |
| FCF MarginFCF / Revenue | 6.2% | — |
| Capex IntensityCapex / Revenue | 17.2% | — |
| Cash ConversionOCF / Net Profit | 1.80× | — |
| TTM Free Cash FlowTrailing 4 quarters | $377.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $183.3M | — | ||
| Q3 25 | $125.7M | — | ||
| Q2 25 | $196.5M | $-9.4M | ||
| Q1 25 | $63.8M | — | ||
| Q4 24 | $147.7M | $184.0M | ||
| Q3 24 | $98.5M | — | ||
| Q2 24 | $96.5M | $11.2M | ||
| Q1 24 | $87.6M | — |
| Q4 25 | $48.2M | — | ||
| Q3 25 | $100.1M | — | ||
| Q2 25 | $177.9M | $-10.5M | ||
| Q1 25 | $51.5M | — | ||
| Q4 24 | $94.1M | $-42.7M | ||
| Q3 24 | $71.8M | — | ||
| Q2 24 | $74.0M | $7.5M | ||
| Q1 24 | $65.5M | — |
| Q4 25 | 6.2% | — | ||
| Q3 25 | 14.2% | — | ||
| Q2 25 | 27.4% | -11.3% | ||
| Q1 25 | 9.1% | — | ||
| Q4 24 | 15.7% | -5.3% | ||
| Q3 24 | 13.2% | — | ||
| Q2 24 | 15.1% | 6.8% | ||
| Q1 24 | 14.8% | — |
| Q4 25 | 17.2% | — | ||
| Q3 25 | 3.6% | — | ||
| Q2 25 | 2.9% | 1.2% | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | 9.0% | 28.0% | ||
| Q3 24 | 4.9% | — | ||
| Q2 24 | 4.6% | 3.4% | ||
| Q1 24 | 5.0% | — |
| Q4 25 | 1.80× | — | ||
| Q3 25 | 1.43× | — | ||
| Q2 25 | 8.73× | -0.45× | ||
| Q1 25 | 1.80× | — | ||
| Q4 24 | 1.47× | 1.88× | ||
| Q3 24 | 1.27× | — | ||
| Q2 24 | 0.51× | — | ||
| Q1 24 | 1.70× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PODD
| U.S.Omnipod | $567.8M | 72% |
| International Omnipod | $214.0M | 27% |
| Drug Delivery | $1.9M | 0% |
RJET
| United Airlines | $517.5M | 48% |
| Delta Air Lines | $409.7M | 38% |
| Other | $49.9M | 5% |
| Republic Airways Holdings Inc. | $42.2M | 4% |
| Other Airlines | $25.7M | 2% |
| LIFT Academy | $23.2M | 2% |
